Compass Pathways (NASDAQ: CMPS), a leading developer in psychedelic therapy, stands at the forefront of innovative treatments for mood disorders. This makes it an exciting, albeit high-risk, investment opportunity. However, the potential for substantial returns is significant, especially with two major catalysts on the horizon that could alleviate much of the associated risk and potentially…